Rocket Doctor AI: Proof That Branding Matters (and So Do Revenues)

This article is disseminated by Rocket Doctor AI

So that disclosure up there, is the only part of this article I know I am writing. I have an advertising contract, which means I have to tell you every time I put pen to paper….or fingers to keyboard.

Now that Treatment.com is officially rebranded as Rocket Doctor AI, you may also start seeing my ads for Rocket Doctor AI showing up online. That’s how you’ll know this story is beginning to reach a wider audience. If you’re reading this now, you were here before the crowd. Thank you for critically reading, entertaining my picks, and joining me on the ride.

The Dilemma: Blue Sky vs. Picks & Axes

My dilemma is where to start. Do I lead with the blue sky, the Global Library of Medicine (GLM) or its AI Nurse that literally is designed to think like a doctor? Or do I lead with the picks-and-axes reality, a digital health platform already serving over 600,000 patients with 300+ doctors and contracts in two of the biggest U.S. states?

The truth is, Rocket Doctor AI is both.

The Demo: Seeing Is Believing

I sat down with Dr. Hamza, the CEO, and we went through their patient facing and physician facing demos. If you are interested in the company, take half an hour of your time and watch this. I cannot do the GLM justice with words. The GLM doesn’t just spit out answers, it triages like a real doctor, recalculating diagnoses as new details emerge.

In the demo, a patient presents with chest pain. The AI asks questions, adjusts probabilities in real time, switches languages instantly, and ultimately directs the patient to immediate medical care.

This is not another ChatGPT clone for healthcare. It’s curated, validated clinical data with over 1,000 diseases and 17,000+ symptoms. Wide guardrails, not narrow scripts. Scalable across entire populations.

The Chart: Cup & Handle Forming

When I first brought Rocket Doctor AI to your attention, it was trading at 28¢. Not exactly a comfortable entry, given the stock had collapsed from its IPO highs.

But now? The Canadian ticker has switched to AIDR, short for AI Doctor and the company has been rebranded as Rocket Doctor AI. I expect the U.S. symbol to transition soon as well.

And the chart is quietly telling a different story: a textbook cup and handle formation. The rim sits at 75¢. If it breaks above that level, the measured move projects into the $1.20–$1.50 range. We are up over 50% now and that first target is more than a double from here.

The Revenue Reality: $18 Per Patient

Simple math: $18 per U.S. patient visit, Medicaid contracted

Rocket Doctor isn’t just a concept; it’s already generating revenue.

The model is simple:

• $18 USD per U.S. patient visit

• Covered lives through Medicaid (patients pay nothing out of pocket)

• Rocket Doctor takes its cut while doctors and patients both benefit

The California contract alone covers 450,000 Medicaid patients. New York Medicaid has a targeted 6.9 million population. Even a modest penetration rate creates the possibility of quickly scaling into millions in ARR. Do the math for yourself.

So far, Rocket Doctor has already facilitated 600,000+ patient visits and onboarded 300–400 doctors. That’s traction.

Don’t get me wrong, this is not a Medicaid story. These are two very large states that have chosen to utilize the platform. I fully expect to see large insurers and physician networks to start getting onboard.

The Blue Sky: GLM + AI Nurse

Curated AI, not generative guesswork.

Here’s the crown jewel: the Global Library of Medicine (GLM) is a proprietary, clinician-curated platform covering 1,000+ diseases and 17,000 symptoms. Unlike generative AI, it does not “hallucinate.” Instead, every data point is built through structured content development and physician-led review, ensuring outputs are accurate, explainable, and safe for clinical use.

Now layer on the possibility of AI Nurse, either as a chatbot or a voice AI solution built with conversational AI tech. Available 24/7, it has the potential to:

• Triage patients before a doctor sees them

• Capture intake notes automatically

• Follow up post-discharge

• Save doctors 40-60% of their admin time

Compare the comps:

• OpenEvidence (valuation: $3.5B)

• Hippocratic AI (valuation: $1.64B)

Rocket Doctor AI? Roughly $35M market cap. I want you to think about that for a minute and let me know what you think this company could be worth….. You can wait until the fins come out or drop in the chat now. I want to hear from everyone where they think it could go.

The Next Catalyst: Financials

Upcoming financials will be the moment revenues meet the narrative.

Here’s the kicker: the financials haven’t yet shown Rocket Doctor’s revenues. That’s why the market is asleep. But those numbers are coming soon.

Here is what we know:

• $18 per U.S. patient visit

• Medicaid populations in California and New York

• Hundreds of thousands of patients already onboarded

• A growing physician networkWhen those revenues hit the reports, the story will be harder to ignore.

Final Thoughts

Rocket Doctor AI is rare:

• Revenue reality → $18 per patient, Medicaid friendly

• Blue sky → GLM + AI Nurse, billion-dollar comps

• Technical setup → Cup & handle breakout forming at 75¢

• Brand clarity → AIDR (AI Doctor) tickerIf you’ve been with me since 28¢, thank you. If you’re new, welcome. Either way, this looks like it is just the beginning.For more information you can go here: https://stocktok.org/rocket-doctor-ai